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Meta-analysisBackground: Alcohol dependence (AD) carries a high mortality burden, which may be mitigated by reduced
alcohol consumption. We conducted a systematic literature review and meta-analysis investigating the risk of
all-cause mortality in alcohol-dependent subjects.
Methods: MEDLINE, MEDLINE In-Process, Embase and PsycINFO were searched from database conception
through 26th June 2014. Eligible studies reported all-cause mortality in both alcohol-dependent subjects and a
comparator population of interest. Two individuals independently reviewed studies. Of 4540 records identiﬁed,
39 observational studies were included in meta-analyses.
Findings:We identiﬁed a signiﬁcant increase inmortality for alcohol-dependent subjects comparedwith the gen-
eral population (27 studies; relative risk [RR]= 3.45; 95% CI [2.96, 4.02]; p b 0.0001). Themortality increasewas
also signiﬁcant compared to subjects qualifying for a diagnosis of alcohol abuse or subjects without alcohol use
disorders (AUDs). Alcohol-dependent subjects continuing to drink heavily had signiﬁcantly greater mortality
than alcohol-dependent subjects who reduced alcohol intake, even if abstainers were excluded (p b 0.05).
Interpretation: ADwas found to signiﬁcantly increase an individual's risk of all-causemortality.While abstinence
in alcohol-dependent subjects led to greater mortality reduction than non-abstinence, this study suggests that
alcohol-dependent subjects can signiﬁcantly reduce their mortality risk by reducing alcohol consumption.
© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Alcohol use is one of the greatest risk factors for disease and disabil-
ity (Rehm, 2011; Nutt et al., 2010; Rehm et al., 2009), and alcohol
dependence (AD) seems to account for the majority of this burden
(Rehm et al., 2012; Rehm et al., 2013). The risk of mortality has been
shown to increase as alcohol consumption increases, both for lifetime
risk and absolute annual risk, with absolute annual risk almost doublingrd Lyon I, 43 Boulevard du 11
),
n-Hughes),
.daeppen@chuv.ch
. This is an open access article underas alcohol consumption increases from 10 g/day to 100 g/day (Rehm
et al., 2011). In addition to the clinical burden of AD experienced by
individuals (François et al., 2014), AD has wider societal consequences,
including substantial direct and indirect economic costs (Rehm et al.,
2012; Laramée et al., 2013).
Until the 1970s, alcohol use disorders (AUDs) were widely called
‘alcoholism’; by this time, however, it was apparent that AD could be
considered as a separate diagnosis (Edwards and Gross, 1976). The
current version of the International Classiﬁcation of Diseases (ICD-10)
continues to categorise harmful use and AD as separate diagnoses
(World Health Organization, 1992), while the latest edition of the
Diagnostic and Statistical Manual of Mental Disorders (DSM-5) has
integrated alcohol abuse and AD into a single AUD diagnosis
(American Psychiatric Association, 2013). In clinical practice, there is
often no formal assessment of diagnoses (ie. alcohol abuse vs AD), but
for treatment in specialised healthcare services it is safe to assumethe CC BY license (http://creativecommons.org/licenses/by/4.0/).
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corresponding to AD (Rehm et al., 2015a).
Previous systematic literature reviews (SLRs) and meta-analyses
have examined the relative risk (RR) of all-cause or cause-speciﬁc mor-
tality in people with AUDs compared with the general population or
with controlled drinkers (Roerecke et al., 2013; Roerecke and Rehm,
2014; Roerecke and Rehm, 2013). One meta-analysis found an RR of
3.38 (95% CI [2.98, 3.84]) for men and 4.57 (95% CI [3.86, 5.42]) for
women in clinical settings compared to the general population
(Roerecke and Rehm, 2013); another found that individuals treated
for AUDs reduced their mortality risk by more than half if they were
able to reduce their alcohol consumption, compared to those individ-
uals who continued to drink heavily (Roerecke et al., 2013). However,
to our knowledge there are currently no systematic reviews focusing
on the risk of all-causemortality in alcohol-dependent individuals only.
Treatment for AD, and AUDs more widely, has traditionally focused
on promoting abstinence as the only acceptable treatment goal. Howev-
er, some patients may prefer a goal of non-problem drinking (Wallhed
Finn et al., 2014). In recent years, there has been an increased emphasis
on an alternative harm-reduction approach that attempts to help
alcohol-dependent patients achieve a reduction in alcohol consumption
without the need to completely abstain, consequently reducing the risk
of harmful consequences associated with alcohol use (European Medi-
cines Agency (EMA), 2010; National Institute for Health and Care
Excellence (NICE), 2011). Reduced consumption of alcohol in individ-
uals with AUDs has been shown to be beneﬁcial, resulting in a signiﬁ-
cant reduction in mortality compared to continued heavy drinking
(Roerecke et al., 2013), and is also predicted to improve the associated
economic and societal burdens (Laramée et al., 2014).
In this study, we aimed to conduct an SLR and meta-analysis on the
increased risk of all-cause mortality among individuals with AD
compared to the general population, individuals without AUDs, and
individuals qualifying for a diagnosis of alcohol abuse; and to examine
the key factors affecting this risk. We also aimed to review the effect
of reduced alcohol consumption among alcohol-dependent individuals.2. Methods
2.1. Systematic Literature Review
An SLR was conducted in accordance with PRISMA guidelines
(Moher et al., 2015) to identify studies reporting on mortality in
alcohol-dependent subjects. MEDLINE, MEDLINE In-Process, Embase
and PsycINFO were searched using the Ovid SP platform, and the
Cochrane Library was searched using theWiley Online platform. Search
strings included terms relating to AD and mortality (Supplementary
Tables 1 and 2). All searches were conducted on 26th June 2014; data-
bases were searched for studies published from database conception
up to that date.
Titles and abstracts of all studies identiﬁed in the database searches
were screened using pre-deﬁned eligibility criteria. Full texts for all po-
tentially eligible studieswere acquired and screened again. Screening at
both stages was performed independently by two reviewers, with
disagreements resolved by consensus or third-reviewer arbitration.
Studies were included if they were published in English andmet the
following criteria: they reported on subjects with AD; the study design
was a randomised controlled trial (RCT), non-RCT, prospective observa-
tional study, retrospective cohort study, nested case–control study, sys-
tematic review or meta-analysis; mortality outcomes were reported for
alcohol-dependent subjects; mortality in alcohol-dependent subjects
was compared to mortality in an appropriate comparator population
(including the general population, subjects without AUDs, subjects
qualifying for a diagnosis of alcohol abuse, or alcohol-dependent
subjects with differing levels of alcohol consumption); and a measure
of association (hazard ratio [HR], odds ratio [OR], RR, standardisedmortality ratio [SMR]) with 95% conﬁdence intervals (CIs), or sufﬁcient
data to calculate these, was reported.
The “general population” comparator subgroup represented an un-
selected population of individuals in terms of drinking behaviour. This
control group could therefore include a mixture of alcohol-dependent
subjects, subjects qualifying for a diagnosis of alcohol abuse, abstinent
subjects or individuals with any other level of pathological or non-
pathological drinking. On the other hand, “subjects without AUDs”
could be deﬁned in a study as “non-alcoholics”, “subjects without AD
or alcohol abuse diagnosis” or any similar deﬁnition.
Studies involving alcohol-dependent subjects were included irre-
spective of whether a formal deﬁnition of AD (e.g. ICD or DSM) had
been used to identify them. For studies involving "alcoholics", the
deﬁnition of alcoholism was reviewed to determine whether it was
operationally similar to a diagnosis of AD (included) or alcohol abuse
(excluded).
The reference lists of all included full texts were scanned for further
potentially relevant studies. These studies then underwent full text
review using the same criteria as studies identiﬁed in the database
searches.
The study design, methodology, patient population parameters and
outcomes for all studies included in the SLR were extracted into a pre-
speciﬁed grid. Data extraction was performed by a single individual
with independent veriﬁcation by a second reviewer, with disagree-
ments resolved by consensus or third-reviewer arbitration. It was
planned that the quality and potential for bias of included RCTs would
be assessed using the criteria provided by the York Centre for Reviews
and Dissemination (Centre for Reviews and Dissemination, 2009) and
the quality of non-RCTs would be assessed using the TREND checklist
(Des Jarlais et al., 2004). The quality of observational studies was
assessed using a checklist designed by the International Society for
Pharmacoeconomics and Outcomes Research (ISPOR) Good Research
Practices Taskforce, which includes domains for relevance and credibil-
ity. Credibility questions related to study design and data analysis,
among others (Berger et al., 2014). Quality assessmentswere conducted
from the perspective of the populations and outcomes of interest to this
review. All studies found to be relevant and credible were eligible for
meta-analysis.
2.2. Meta-Analyses
Meta-analyses were conducted in accordance with MOOSE guide-
lines (Stroup et al., 2000). Results from the included studies were
pooled for meta-analysis by comparator population. Given themethod-
ological heterogeneity of studies identiﬁed in this SLR (e.g. differences
between studies in mean age, source of the alcohol-dependent popula-
tion, and reference groups) a random-effects model was judged to be
appropriate for this meta-analysis (parallel analyses used ﬁxed-effect
models). HRs, ORs, RRs and SMRs were assumed to approximate the
same measure of risk (Rothman and Greenland, 1998).
Included studies were pooled for meta-analyses based on measures
of association being available for the following comparisons: alcohol-
dependent subjects vs the general population, subjects without AUDs,
or alcohol abusing subjects; or alcohol-dependent subjects who contin-
ued to drink heavily vs alcohol-dependent subjects who reduced their
alcohol intake (abstainers excluded), alcohol-dependent subjects
who reduced their alcohol intake (abstainers included), or abstinent
alcohol-dependent subjects.
Where the same patients were included in two or more studies, the
study involving the greatest number of alcohol-dependent subjects was
included in the meta-analysis.
To test the robustness of the ﬁndings, subgroupmeta-analyses were
performedwithin studies that compared alcohol-dependent subjects vs
the general population, by a number of pre-speciﬁed study- and
patient-level characteristics. This included a subgroup analysis by the
deﬁnition of AD used within the study (strictly deﬁned AD, such as
1396 P. Laramée et al. / EBioMedicine 2 (2015) 1394–1404DSM or ICD criteria vs another deﬁnition vs no reported deﬁnition). It
was not possible to perform subgroup analyses for the other compari-
son groups due to the limited number of studies and insufﬁcient power.
Random-effects were estimated using the approach of DerSimonian
and Laird (1986), with the estimate of heterogeneity being taken from
the Mantel–Haenszel model (Mantel and Haenszel, 1959). Summary
RRs and 95% CIswere calculated by pooling the study-speciﬁc estimates.
Stata® statistical softwarewasused, in particular, theMETAN command
written for Stata®v11.1 (Anon, 2013). Consistency ofﬁndings across in-
dividual studies was assessed by standard χ2 tests and the I2 statistic
(Higgins et al., 2003). Statistical tests were two-sided and used a signif-
icance level of p b 0.05. Publication bias was assessed by funnel plots
and Egger's tests (Egger et al., 1997).
2.3. Role of the Funding Source
The study sponsor was involved in the design of the review and its
protocol, the review of the data collection and statistical analysis, and
the interpretation of the results. The study sponsor was not involved
in the collection or extraction of data, or in the performance of statistical
analyses. All authors were involved in the writing of the report and the
decision to submit the manuscript for publication.
3. Results
Of the 4540 records identiﬁed through the database searches and
hand searches, 177 were selected for full-text review and 47 (including
two systematic reviews (Roerecke and Rehm, 2014; Roerecke and
Rehm, 2013) and 45 primary research studies) were ultimately includ-
ed in the qualitative synthesis of results (Fig. 1). Of the 45 primaryFig. 1. PRISMAresearch studies, three were unsuitable for inclusion in the quantitative
synthesis. Of these, two studies duplicated data on subjects from other
included studies (de Lint and Schmidt, 1970; Martin et al., 1985a). The
third studywas excluded since it compared alcohol-dependent subjects
vs abstinent subjects without AUDs; no other studies included in the
SLR reported an equivalent comparison, so a meta-analysis was not
conducted (Dawson, 2000).
Following a thorough quality appraisal, results from three studies
were judged to be insufﬁciently credible for meta-analysis due to
a lack of information presented about key components of their protocols
(Bell and Orjasaeter, 1983; Fitzgerald et al., 1971; Kessel and Grossman,
1961). The quality of the included studies varied substantially.
Frequently-encountered limitations included the lack of a reported
deﬁnition for AD and results presented without conﬁdence intervals
or without adjustment for confounders. Summaries of the credibility
domain of the quality appraisals are presented in Supplementary
Table 3 for all studies included in the SLR. Thirty-nine studies included
in the SLR were ultimately eligible for meta-analysis (Table 1).
The majority of the studies included in the meta-analyses (28/39)
involved patients selected from AD treatment facilities (Berglund and
Tunving, 1985; Campos et al., 2011; de Lint and Levinson, 1975;
Denison et al., 1997; Feuerlein et al., 1994; Finney and Moos, 1991;
Gerdner and Berglund, 1997; Gillis, 1969; Gual et al., 2009; Haver
et al., 2009; Hiroeh et al., 2008; Johnson, 2001; Mackenzie et al., 1986;
Marshall et al., 1994; Martin et al., 1985b; Moos et al., 1994; Noda
et al., 2001; Rankin et al., 1970; Saieva et al., 2012; Schmidt and de
Lint, 1969; Smith et al., 1983; Storbjörk and Ullman, 2012; Tashiro and
Lipscomb, 1963; Thorarinsson, 1979; Vaillant et al., 1983; Wells and
Walker, 1990; Yoshino et al., 1997; De Silva and Ellawala, 1994). Two
studies involved patients from hospital populations (Poser et al., 1992;ﬂowchart.
Table 1
Characteristics of the 39 primary research studies on AD and all-cause mortality included in the meta-analyses.
Study Sex Location Study design Baseline
age of
subjects
(years)
Time
period
Maximum
follow-up
(years)
Number of
alcohol-dependent
individuals
Setting and subjects Deﬁnition of AD Comparison groups used
Berglund and Tunving
(1985)
M Sweden Prospective
cohort
Mean 42 1960 to
1980
20 257 Alcoholics treated at the outpatient
alcoholic unit at the University
Hospital, Lund
NR AD vs general population
Campos et al. (2011) M,
F
Spain Retrospective
cohort
18 to 89 1996 to
2006
10 1265 Admissions to a university hospital
in Spain who were either admitted
for alcohol withdrawal syndrome
(AWS) or developed AWS during
admission
ICD-9-CM AWS AD vs general population
de Lint and Levinson
(1975)
M,
F
Canada Prospective
cohort
20 to 74 1969 to
1974
5 154 Admissions to the Donwood
Institute who were addicted
primarily to alcohol
Addicted primarily to alcohol AD vs general population
De Silva and Ellawala
(1994)
M Sri Lanka Prospective
cohort
Mean 39 1986 to
1991
6 188 Alcohol-dependent men admitted
to the Sumithrayo Rehabilitation
Unit
World Health Organization (WHO)
1951 deﬁnition (“an excessive
intake of alcohol leading to physical,
psychological or social harm”)
AD vs general population; AD with
continued heavy drinking vs
reduced intake
Denison et al. (1997) M Sweden Prospective
cohort
≥20 1986 to
1991
5 1049 Alcohol-dependent men treated as
inpatients in the detoxiﬁcation
ward at the University Psychiatric
Clinic, Lillhagen Hospital, Göteborg
DSM-III-R AD AD vs general population
Feuerlein et al. (1994) M,
F
Germany Prospective
cohort
≥20 1981 to
1985
4 1401 Alcoholics treated at 21 different
treatment centres in West
Germany
NR AD vs general population
Finney and Moos
(1991)
M,
F
USA Prospective
cohort
NR NR 8 113 Alcoholic patients treated in one of
ﬁve residential facilities who
returned to family settings
NR AD vs general population; AD with
continued heavy drinking vs
reduced intake
Gerdner and Berglund
(1997)
M,
F
Sweden Prospective
cohort
26 to 63 1985 to
1994
8.5 116 Patients competing a ﬁve-week
Alcoholics Anonymous-oriented
programme at Runnagarden Social
Welfare Institution
AD (diagnostic criteria NR) AD vs general population; AD with
continued heavy drinking vs
reduced intake
Gillis (1969) M,
F
South
Africa
Prospective
cohort
20 to 74 1959 to
1965
6 802 Chronic alcoholic white patients
admitted to three treatment centres
in South Africa
Chronic addictive alcoholics AD vs general population
Gual et al. (2009) M,
F
Spain Prospective
cohort
18 to 55 1987 to
2008
20 850 Alcohol-dependent patients who
had accepted to enter a treatment
programme, and who had a stable
home with at least one other family
member
DSM-III AD AD with continued heavy drinking
vs reduced intake
Haver et al. (2009) F Sweden Prospective
cohort
Mean
42.5
1981 to
2007
25 420 Subjects receiving their ﬁrst
treatment at the Early Treatment
for Women with Alcohol Addiction
programme at Karolinska Hospital,
Stockholm
Alcohol addiction AD vs general population
Hiroeh et al. (2008) M,
F
Denmark Retrospective
cohort
≥15 1973 to
1993
21 NR (275,874
person-years)
All Danish adults aged 15 years or
over, identiﬁed through the Danish
Civil Registration System
ICD-8 alcoholism AD vs general population
John et al. (2013) M,
F
Germany Prospective
cohort
18 to 64 1996 to
2010
14 147 Random sample of the general
population of Germany
DSM-IV AD AD vs general population; AD with
continued heavy drinking vs
reduced intake
Johnson (2001) M,
F
UK Retrospective
cohort
47 to 74 1978 to
1998
20 100 Subjects who attended the Robert
Smith Unit, a day centre for the
treatment of alcohol problems in
ICD-10 AD AD vs general population
(continued on next page)
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Table 1 (continued)
Study Sex Location Study design Baseline
age of
subjects
(years)
Time
period
Maximum
follow-up
(years)
Number of
alcohol-dependent
individuals
Setting and subjects Deﬁnition of AD Comparison groups used
Bristol, as part of their ﬁrst referral
for treatment
Mackenzie et al. (1986) M USA Prospective
cohort
Mean 41 1969 to
1979
8.2 85 Male alcoholics who had
participated in the Francis Scott Key
Medical Center inpatient alcoholism
research programme
NR AD vs general population
Markkula et al. (2012) M,
F
Finland Prospective
cohort
30 to 70 2000 to
2008
8 6372 Participants in the Health 2000
Study, a nationally representative
sample of Finnish people
DSM-IV AD AD vs alcohol abuse
Marshall et al. (1994) M UK Prospective
cohort
39 to 43 1968 to
1990
20 99 Married men with a diagnosis of
alcoholism but no psychotic illness,
who attended the specialist alcohol
problems clinic at Maudsley
Hospital, London
NR AD vs general population
Martin et al. (1985b) M,
F
USA Prospective
cohort
14 to 84 1967 to
1979
12 70 Outpatients admitted to the
Washington University Psychiatry
Clinic
Similar to Feighner Criteria AD vs general population
Mattisson et al. (2011) M,
F
Sweden Prospective
cohort
Median
27
(M)/16
(F)
1947 to
1997
50 208 The Lundby Cohort, comprising all
subjects living in Lundby District
DSM-IV AD AD vs alcohol abuse
Min et al. (2008) M,
F
South
Korea
Nested
case–control
22 to 82 1998 to
2004
6 59 Adults living in Guyrae-myon
village
≥16 on the Severity of Alcohol
Dependence Questionnaire (SADQ)
for men; ≥10 on the SADQ for
women
AD vs no AUDs
Moos et al. (1994) M,
F
USA Prospective
cohort
≥55 1986 to
1991
4 12,309 AD patients in Department of
Veterans Affairs (VA) Medical
Centers
ICD-9-CM AD AD vs general population
Murphy et al. (2008) M,
F
Canada Prospective
cohort
18 to 88 1952 to
1992
40 NR Heads of household in Stirling
County
Psychiatric diagnosis of alcoholism
with high conﬁdence
AD vs general population
Neumark et al. (2000) M,
F
USA Prospective
cohort
≥18 1981 to
1996
14 284 Adult household residents living in
the Baltimore Epidemiologic
Catchment Area
DSM-III AD AD vs no AUDs
Noda et al. (2001) M Japan Prospective
cohort
21 to 77 1972 to
1992
20 306 Patients diagnosed with alcoholism
at a psychiatric institution
Alcoholism (Japanese Committee
for the Diagnosis of Alcoholism
criteria)
AD vs general population
Pell and D'Alonzo
(1973)
M,
F
USA Prospective
cohort
Median
51.1
1963 to
1969
5 899 Active or retired (with pension)
employees of the DuPont company
Persons who exhibit alcohol
dependency, drinking patterns and
behavioural characteristics such as
disturbed personal relations and
impaired work efﬁciency, that
clearly demonstrate they are
chronic, uncontrolled
alcoholics
AD vs no AUDs; AD with continued
heavy drinking vs reduced intake
Perälä et al. (2010) M,
F
Finland Prospective
cohort
≥30 2000 to
2008
8 443 Participants in the Health 2000
Study, a nationally representative
sample of Finnish people
DSM-IV AD AD vs no AUDs
Poser et al. (1992) M,
F
Germany Prospective
cohort
Mean
28.7
1974 to
1991
17 620 Patients with known AD who had
any contact with the psychiatric or
neurological department of the
University Hospital of Göttingen for
therapy or expert opinion
DSM-III AD AD vs general population
Rankin et al. (1970) M,
F
Australia Prospective
cohort
NR 1964 to
1969
4.75 56 Alcoholics with cirrhosis, attending
the Alcoholism Clinic at St. Vincent's
NR AD with continued heavy drinking
vs reduced intake
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Hospital, Melbourne
Saieva et al. (2012) M,
F
Italy Prospective
cohort
14 to 93 1985 to
2006
21.7 2272 Alcoholic residents of Tuscany,
treated at the Alcohol Centre of
Florence
ICD-9 AD AD vs general population
Schmidt and de Lint
(1969)
M,
F
Canada Prospective
cohort
≥15 1951 to
1966
14 6514 Patients admitted to the Toronto
Clinic of the Addiction Research
Foundation
NR AD vs general population
Smith et al. (1983) F USA Prospective
cohort
18 to 67 1967 to
1980
11 103 Women diagnosed with alcoholism
at two psychiatric hospitals in the
St. Louis area
Feighner Criteria AD vs general population; AD with
continued heavy drinking vs
reduced intake
Storbjörk and Ullman
(2012)
M,
F
Sweden Prospective
cohort
Mean
43.3
2000 to
2008
8 929 Patients from 21 treatment units,
who started treatment for AD that
they had not previously been given
at the same treatment unit during
the previous six months
ICD-10 AD AD vs no AUDs
Tashiro and Lipscomb
(1963)
M,
F
USA Prospective
cohort
20 to 79 1954 to
1958
5 1692 Individuals admitted to four
alcoholism treatment facilities in
California
NR AD vs general population
Thorarinsson (1979) M Iceland Prospective
cohort
Mean 37 1951 to
1974
23 2863 First-admission alcoholic males
treated as either an outpatient or an
inpatient at one of three clinics, or
identiﬁed as attending a private
clinic by the Psychiatric Register of
Iceland
NR AD vs general population
Vaillant et al. (1983) M,
F
USA Prospective
cohort
NR 1972 to
1980
8 110 Patients admitted for alcohol
withdrawal to the inpatient ward at
the Cambridge and Somerville
Program for Alcohol Rehabilitation
at the Cambridge Hospital
Patients with alcohol withdrawal
who required ≥750 mg of
chlorodiazepoxide during
detoxiﬁcation or who revealed signs
of severe withdrawal such as
seizures or delirium tremens during
prior admissions
AD with continued heavy drinking
vs reduced intake
Vaillant (2003) M USA Prospective
cohort
9 to 20 1940 to
2000
23 91 College cohort: Male Harvard
University sophomores selected for
a study of normal development,
with no known physical or mental
illness at baseline
Core city cohort: Men studied from
early adolescence as a
non-delinquent community control
group for a study of
institutionalised juvenile
delinquents
DSM-III AD AD vs no AUDs; AD vs alcohol abuse
Wallerstedt et al.
(1995)
M Sweden Prospective
cohort
17 to 79 1980 to
1987
7 52 Patients in the medical, surgical and
orthopaedic wards of the Ostra
Hospital, Göteborg
Patients with presence of one or
more of the following criteria:
interview reports of altered
reactions to alcohol or notes on
alcohol addiction in their case ﬁles;
treatment for alcohol addiction at a
psychiatric clinic; registration by
the social authorities for alcohol
addiction
AD vs general population
Wells and Walker
(1990)
M,
F
New
Zealand
Prospective
cohort
≥15 1972 to
1984
11 616 Alcoholic patients admitted to
Mahu Clinic, Sunnyside Hospital,
Christchurch
NR AD vs general population
Yoshino et al. (1997) M Japan Prospective
cohort
Mean
50.1
1989 to
1996
3 74 Alcoholics hospitalised at the
Komagino Hospital Alcoholism
Treatment Unit for a detoxiﬁcation
and rehabilitation programme
DSM-III AD AD vs alcohol abuse
AD, alcohol dependence; AWS, alcohol withdrawal syndrome; DSM, Diagnostic and Statistical Manual of Mental Disorders; F, female; ICD, International Classiﬁcation of Diseases; M, male; NR, not reported; SADQ, Severity of Alcohol Dependence
Questionnaire; WHO, World Health Organization.
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treated for AD. Eight studies identiﬁed alcohol-dependent subjects
from general population surveys (Mattisson et al., 2011; John et al.,
2013; Markkula et al., 2012; Min et al., 2008; Murphy et al., 2008;
Neumark et al., 2000; Perälä et al., 2010; Vaillant, 2003), and a single
study was based on a survey of company employees (Pell and
D'Alonzo, 1973). Only four studies included in the meta-analyses re-
ported mean daily or weekly alcohol consumption among alcohol-
dependent subjects (Finney and Moos, 1991; Haver et al., 2009;
Johnson, 2001; Perälä et al., 2010).
The most commonly reported comparison was alcohol-dependent
subjects vs the general population, which was reported in 27/39 of the
studies eligible for meta-analysis, with a total of 13,523 deaths in the
alcohol-dependent populations (Fig. 2a). The majority of studies in
this category determined the expected death rate of the alcohol-
dependent sample based on age- and sex-matched data from demo-
graphic records from the city or country of the study. The pooled RR cal-
culated from these studies was 3.45 (95% CI [2.96, 4.02]; p b 0.0001).
Heterogeneity between studies was high (I2 = 97.9%; p b 0.0001).
Other all-cause mortality comparisons investigated in the
meta-analyses included: alcohol-dependent subjects vs subjects
without AUDs (six studies; RR = 1.87; 95% CI [1.46, 2.40]; p b
0.0001) (Fig. 2b); alcohol-dependent subjects vs subjects qualifying
for a diagnosis of alcohol abuse (four studies; RR = 1.25; 95% CI [1.05,
1.48]; p = 0.012) (Fig. 2c); alcohol-dependent subjects who continued
to drink heavily vs alcohol-dependent subjects who reduced their alco-
hol intake, excluding abstainers (ﬁve studies; RR = 1.60; 95% CI [1.00,
2.55]; p = 0.049) (Fig. 3a); alcohol-dependent subjects who continued
to drink heavily vs alcohol-dependent subjects who reduced their alco-
hol intake, including abstainers (nine studies; RR = 1.71; 95% CI [1.23,
2.39]; p = 0.002) (Fig. 3b); and alcohol-dependent subjects who con-
tinued to drink heavily vs abstinent alcohol-dependent subjects (three
studies; RR = 3.03; 95% CI [1.63, 5.65]; p b 0.0001) (Fig. 3c).
Subgroup analyses within studies that compared alcohol-dependent
subjects with the general population (Supplementary Fig. 1) indicated
evidence of heterogeneity by level of adjustment and length of follow-
up (p-value from meta-regression on each covariate; p = 0.02 and
p = 0.03, respectively); a lower level of adjustment or a shorter
follow-up corresponded to a higher RR. Furthermore, there was a no-
ticeable difference inmortality between alcohol-dependent subjects se-
lected from general population surveys (RR= 1.76; 95% CI [1.48, 2.09])
and alcohol-dependent subjects selected from treatment centres (RR=
3.65; 95% CI [3.10, 4.30]) or hospitals (RR = 3.49; 95% CI [2.37, 5.12]).
The deﬁnition of AD used in a study (DSM or ICD AD vs other deﬁnition
vs no reported deﬁnition) did not have a signiﬁcant effect on the RR
(p = 0.86).
There was no evidence of publication bias across studies that report-
ed on alcohol-dependent subjects vs the general population, alcohol-
dependent subjects vs subjects qualifying for a diagnosis of alcohol
abuse, or alcohol-dependent subjects with continued heavy drinking
vs alcohol-dependent subjects who reduced their drinking (p N 0.05 in
Egger's asymmetry test). However, there was evidence of publication
bias for analyses that compared alcohol-dependent subjects to subjects
without AUDs (Egger's asymmetry test of associations: p = 0.01)
(Supplementary Fig. 2).4. Discussion
In these meta-analyses, alcohol-dependent individuals were found
to have a signiﬁcantly increased risk of all-cause mortality compared
to the general population. However, heterogeneity between studies
was high. While in subgroup analyses the deﬁnition of AD reported in
a study (strict AD vs any other deﬁnition vs no deﬁnition reported)
did not affect the pooled RR estimates, differing levels of adjustment be-
tween studies (e.g. adjustment for age, sex and smoking vs unadjustedcomparisons) and length of follow-up were identiﬁed as signiﬁcant
contributors to heterogeneity.
The general population includes individuals with AUDs, and would
therefore be expected to have higher alcohol-attributable mortality
than a cohort without AUDs. The relative risk of mortality for alcohol-
dependent subjects vs the general population should therefore be
lower than the relative risk for alcohol-dependent subjects vs a cohort
without AUDs. However, in this study the opposite was found; a higher
risk estimate for studies comparing alcohol-dependent subjects to the
general population than for studies comparing alcohol-dependent sub-
jects to cohortswithout AUDs. Thismay be explained by considering the
characteristics of the alcohol-dependent population in each case: of the
studies reporting on mortality in alcohol-dependent subjects vs the
general population, the majority involved treated alcohol-dependent
subjects. However, of the six studies reporting on mortality in alcohol-
dependent subjects vs subjects without AUDs, only one study involved
treated alcohol-dependent subjects. Subgroup analyses of studies
comparing alcohol-dependent subjects to the general population
showed that the pooled risk estimate for studies involving treated
alcohol-dependent subjects was higher than for studies involving
alcohol-dependent subjects identiﬁed from general population surveys,
potentially explaining the result above. This reasoning can be further
strengthened by recent studies on characteristics of treated vs untreated
peoplewith AUDs: therewas a substantial differencewith respect to co-
morbid conditions (both for mental and somatic disorders), alcohol
consumption (both average drinking levels and binge drinking
episodes), hospital days and disability (Rehm et al., 2015a; Rehm
et al., 2014).
Although only one out of four studies reporting on mortality in
alcohol-dependent individuals compared to subjects qualifying for a di-
agnosis of alcohol abuse showed signiﬁcantly increased mortality for
alcohol-dependent subjects (Mattisson et al., 2011), the pooled RR
was signiﬁcant. Reduced alcohol consumption without abstinence
was signiﬁcantly associated with a lower risk of death in alcohol-
dependent subjects. Although this was a lower reduction in mortality
than for abstinent alcohol-dependent subjects, the opportunity to
reduce the risk of death combinedwith the preference among some pa-
tients to achieve a non-problem drinking outcome rather than absti-
nence supports the use of controlled drinking as a valid AD treatment
goal (Adamson et al., 2010; Luquiens et al., 2011; Rosenberg et al.,
1992). Achieving a reduction in alcohol consumption, including
among alcohol-dependent subjects who may otherwise not have en-
tered into treatment, would be predicted to ease the overall public
health burden associated with AD (François et al., 2014), as well as re-
ducing both direct and indirect costs (Rehm et al., 2012; Laramée
et al., 2014).
The results of these meta-analyses are consistent with recently pub-
lished meta-analyses on the risk of mortality in individuals with AUDs.
Roerecke and Rehm (2013) reported RRs of 3.38 (95% CI [2.98, 3.84])
and 1.91 (95% CI [1.51, 2.42]) formenwith AUDs identiﬁed from clinical
samples and population surveys, respectively, compared to the general
population (Roerecke and Rehm, 2013). This is broadly in agreement
with the ﬁndings of our subgroup analyses, where the pooled RR for
treated alcohol-dependent subjects was more than double the pooled
RR for alcohol-dependent subjects from population surveys. Although
this may seem counterintuitive, only a minority of individuals with
substance dependence seek treatment for their addiction, and these
individuals tend to have a greater severity of dependence than those
who do not seek help (Grella and Stein, 2013). This may explain the
increasedmortality among treated alcohol-dependent subjects. Our ob-
servations that studies with shorter follow-up periods or with results
adjusted for fewer confounders reported higher RRs were also consis-
tent with previously published results (Roerecke and Rehm, 2013).
In clinical practice, the distinction between alcohol abuse, AD and
AUDs is not always clear. However, given the low treatment rates, and
the comparisons of treated vs untreated individuals with AUDs (Rehm
Fig. 2. Random-effects and ﬁxed-effect meta-analyses of mortality risk in a) alcohol-dependent subjects vs the general population, b) alcohol-dependent subjects vs subjects without
AUDs, and c) alcohol-dependent subjects vs subjects qualifying for a diagnosis of alcohol abuse. aHR, OR, RR or SMR (depending on study); bHR, OR or RR (depending on study);
cCollege cohort; dCore city cohort.
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Fig. 3. Random-effects and ﬁxed-effect meta-analyses of mortality risk in alcohol-dependent subjects with continued heavy drinking vs a) alcohol-dependent subjects who reduced their
alcohol intake (excluding abstainers), b) alcohol-dependent subjects who reduced their alcohol intake (including abstainers), and c) abstinent alcohol-dependent subjects. aHR, OR or RR
(depending on study).
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jority of people in specialised treatment qualify for a diagnosis of AD
(Rehm et al., 2015b). The deﬁnition of AD was carefully considered in
the eligibility criteria for this SLR, and the impact of including studies
where formal deﬁnitions (such as ICD or DSM) had not been used to
identify alcohol-dependent subjects was subsequently evaluated in
sub-group analyses and found to not have a signiﬁcant effect. These fac-
tors may explain why the results of this SLR on AD are similar to previ-
ously published SLRs on AUDs (Roerecke and Rehm, 2013; Harris and
Barraclough, 1998). To our knowledge, there are no previous SLRs or
meta-analyses reporting on mortality in alcohol-dependent individuals
speciﬁcally rather than individuals with AUDs more broadly. Our study
therefore supplements the existing literature onmortality in individuals
with AUDs (Roerecke et al., 2013; Roerecke and Rehm, 2014; Roereckeand Rehm, 2013), supporting the conclusions of previous studies while
providing an important focus on the subgroup of subjects with AD.
One limitation of this study was the exclusion of non-English lan-
guage articles; however, in our subgroup analysis of the studies compar-
ing alcohol-dependent subjects vs the general population – half of
whichwere fromEurope, a third fromNorth America and the remainder
from other locations – therewere no signiﬁcant differences between re-
gions, implying that the inclusion of further studies fromother countries
or continents would not necessarily have signiﬁcantly changed the con-
clusions of this review. Another limitation is thatwe did not exclude un-
adjusted studies from the meta-analyses. This may have affected some
results, as unadjusted studies were found to show a signiﬁcantly larger
effect size in the comparison between alcohol-dependent subjects and
the general population. However, we were unable to conduct subgroup
1403P. Laramée et al. / EBioMedicine 2 (2015) 1394–1404analyses by adjustment level for the other meta-analyses due to the
limited number of studies and insufﬁcient power. Therefore, it is not
possible to determine the direction of any potential effects in these
cases. Finally, it is possible that the risk of mortality in alcohol-
dependent subjects may vary by how long an individual has been
alcohol-dependent for; however, we were unable to investigate this,
as this information was not commonly reported in the included studies.
In our meta-analyses, we have established that alcohol-dependent
individuals who are able to reduce their alcohol consumption reduce
their risk of all-cause mortality, but without further insight into the
causes of death among these individuals we can only speculate about
the mechanism by which this reduction in mortality occurs. It is not
clearwhether a reduction in alcohol consumption among these individ-
uals would lead to a proportional reduction in risk across all causes of
death, or whether the beneﬁts would be greater among speciﬁc causes.
Furthermore, though a meta-analysis has been published on cause-
speciﬁc mortality in individuals with AUDs (Roerecke and Rehm,
2014), none has been published concerning cause-speciﬁc mortality in
individuals with AD speciﬁcally. We therefore recommend that further
research should focus on the risk of cause-speciﬁc mortality in
alcohol-dependent individuals, and particularly in individuals who are
able to reduce their alcohol consumption.
5. Conclusions
Wepresent theﬁnding that AD signiﬁcantly increases an individual's
risk of all-cause mortality compared to the general population, subjects
without AUDs or subjects qualifying for a diagnosis of alcohol abuse.
While abstinence in alcohol-dependent subjects leads to a greater
reduction in mortality than non-abstinence, alcohol-dependent sub-
jects who are able to reduce their alcohol consumption can signiﬁcantly
reduce their risk of death. This ﬁnding reinforces the validity of harm re-
duction and the associated societal beneﬁt through reduced alcohol
consumption as a valid treatment goal alongside abstinence in the
treatment of AD.
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